Clinical Trials Logo

Pain clinical trials

View clinical trials related to Pain.

Filter by:

NCT ID: NCT05104931 Completed - Pain Clinical Trials

PK Evaluation of a Nanoformed Oral IR Piroxicam Tablet in Healthy Subjects

Start date: December 2, 2020
Phase: Phase 1
Study type: Interventional

Piroxicam is a nonsteroidal anti-inflammatory medication and currently used to treat pain and inflammation caused by osteoarthritis or rheumatoid arthritis. The aim of this study is to study the pharmacokinetic behaviour of the new nanoformed 20mg tablet formulation of piroxicam in comparison with a reference 20mg piroxicam tablet formulation. The target of nanoforming is to improve the pharmacokinetic properties of drugs with low solubility, potentially leading to the use of lower doses with concomitant improvements in safety and tolerability. Piroxicam is an appropriate candidate to demonstrate the benefits of nanoforming due to its physiochemical properties. The efficacy of the Nanoformed Piroxicam is evaluated in comparison to the reference product Felden® Tabs 20 mg. The study also is conducted with a second reference product, Brexidol® 20 mg, or a nanoformed piroxicam tablet of a different strength, or study the effect of food intake on the absorption of the nanofomed piroxicam tablet. The study is conducted with healthy volunteers.

NCT ID: NCT05102760 Recruiting - Pain Clinical Trials

PENG vs. FIC Block for Hip Fracture ED Patients

Start date: October 20, 2021
Phase: N/A
Study type: Interventional

Ultrasound-guided nerve blocks are an important tool for treating pain due to orthopedic injury in the ED. They provide long lasting, opioid-sparing pain relief that is generally safe and well-tolerated by patients1. Elderly patients with hip fractures commonly present to the ED, and their injury can be painful. Commonly used opioid pain regimens can have deleterious side effects, especially in elderly patients, like somnolence, delirium, hypotension and respiratory depression. The fascia iliaca compartment (FIC) block has become a familiar technique to emergency physicians as a pain control treatment for hip fractures. The pericapsular nerve group (PENG) block has recently been proposed as a novel method to treat pain due to hip, acetabular and pelvic fracture by targeting the terminal sensory articular nerve branches of the femoral nerve (FN), obturator nerve (ON), and accessory obturator nerve (AON). At this time there has been no study comparing the efficacy of the two nerve blocks, PENG and FIC. This aim of this study is to compare the efficacy of the PENG block (20mL of Bupivacaine 0.50%) to that of the FIC block (40mL of Bupivacaine 0.25%) for patients with hip fractures in the ED. Our hypothesis is that PENG will demonstrate analgesia that is non-inferior to FIC. Subjective pain scores on a scale of 0 to 10 will be assessed before and after the block. All subjects will receive 4mg of morphine after consent and prior to the block.

NCT ID: NCT05101785 Not yet recruiting - Pain Clinical Trials

Articaine 4% Efficacy and Safety in Extraction and Pulpotomy of Primary Molars of Children Below the Age of Four Years

Start date: November 1, 2021
Phase: N/A
Study type: Interventional

compare the anaesthetic efficacy and safety for pain and behaviour for extraction or pulp therapy in primary molars in young children below four years old using 4% articaine and 2% lidocaine local anesthetics.

NCT ID: NCT05097937 Completed - Pain Clinical Trials

Analgesic Mechanisms of Percutaneous Electrolysis

Start date: November 22, 2021
Phase: N/A
Study type: Interventional

Percutaneous electrolysis is based on the application of a galvanic current through an acupuncture needle. The underlying mechanisms that explain the efficacy of this technique are not completely well understood. The objective is to delve into the neurophysiological analgesic effects of percutaneous electrolysis. Participants will be assigned to one of three intervention groups. The analgesic effects of the technique will be evaluated by means of variables related to endogenous pain modulation.

NCT ID: NCT05092906 Completed - Pain Clinical Trials

Contribution of Hypnosis During a Lumbar Puncture.

HYPNOPLUS
Start date: November 9, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the effect of hypnosis, as add on therapy, on patients requiring a lumbar puncture (LP) as part of their medical management.

NCT ID: NCT05088876 Recruiting - Pain Clinical Trials

Paracetamol in Addition to WHO Step III Opioids in Chronic Cancer Pain Control

ParOP
Start date: August 30, 2024
Phase: Phase 4
Study type: Interventional

Blinded withdrawal of regular co-medication with paracetamol in chronic pain patients under strong opioids on pain control.

NCT ID: NCT05085535 Not yet recruiting - Pain Clinical Trials

Study of Manual Therapy Plus Therapeutic Exercise in Geriatrics

Start date: June 8, 2024
Phase: N/A
Study type: Interventional

This research project is part of the process of generating scientific evidence, on whether the clinical results obtained, in the treatment of the consequences of aging on mobility, pain and disability, are better if therapeutic exercise programs are added sessions of manual therapy and training in pain awareness, or on the contrary, do not significantly modify the effect of exercise programs.

NCT ID: NCT05082623 Active, not recruiting - Pain Clinical Trials

The Effect of Music on Delirium, Pain, Need of Sedation, Anxiety and Vital Parameters

Start date: September 14, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to test the effect of a twice daily, 60-minute, nurse initiated, music listening intervention on patients followed in the ICU with MV support as compared to patients who receive care as usual and ear plugs.

NCT ID: NCT05082506 Not yet recruiting - Pain Clinical Trials

Effect of Acupressure on Pain, Anxiety and Vital Signs in Patients With Coronary Angiography

Start date: December 15, 2021
Phase: N/A
Study type: Interventional

The study was planned to determine the effect of acupressure on pain, anxiety and vital signs of patients with coronary angiography. Acupressure application was carried out by the responsible researcher, who is certified on this subject, by TRNC Dr. In the Cardiology Service of Burhan Nalbantoğlu Hospital, patients who have undergone angiography will be applied and measurements will be made before mobilization after their informed consent is obtained.

NCT ID: NCT05082246 Recruiting - Depression Clinical Trials

Impact of Complimentary and Alternative Practices on Patient Wellbeing During Rehabilitation

Start date: January 15, 2022
Phase: N/A
Study type: Interventional

The study's objective is to assess whether CAM methods are feasible and beneficial in the WSRH setting; to assess stress (using the Perceived Stress Scale-14 and using BioSquares™), anxiety (using the Generalized Anxiety Disorder-7 scale), depression (using the Patient Health Questionnaire-9 scale), pain (using the Wong-Baker FACES scale), and vital signs using a multidisciplinary complementary approach with Heartfulness Meditation, Conscious Breathing, and Emotional Freedom Technique - the CAM practices for this study; and, to assess and compare the above scores for each participant just prior to and immediately after each treatment session. The study hypothesizes that using CAM modalities in the WSRH is both feasible and beneficial in that patient population; the patients receiving the CAM modalities of treatment will show an improvement in the above-mentioned scores compared to participant scores prior to the intervention; and there may also be an improvement in patients' vital signs following the intervention of CAM practices.